Our Approach
The Early Phase Clinical Trial Program at Smilow Cancer Hospital opened in 2016 at 55 Park Street in New Haven and is a dynamic hub of Phase I trials. Attractive and state-of-the-art, the Center is at the heart of Yale Cancer Center’s Phase I Clinical Trials Program and is dedicated to the care of patients on Phase I clinical trials.
The Early Phase Clinical Trial Program program affords patients not only hope, but also the ability to participate in research with clinical impact—research that will advance new drugs, which could advance to FDA approval.